Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), bought 14,243 shares at $13.40 ($191K) on 2018-08-24, disclosed to the SEC on 2018-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.52 | 2,202 | $30K | 15.6% |
| 2 | $13.50 | 2,133 | $29K | 15.0% |
| 3 | $13.40 | 4,954 | $66K | 34.7% |
| 4 | $13.40 | 4,954 | $66K | 34.7% |
| Total | $13.43 avg | 14,243 | $191K | 100% |
| Filing → |
| RCUS | SELL | 2022-12-16 | $802K | — | Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |